Molly Carr insider trades
Open-market stock purchases and sales by Molly Carr, Chief Medical Officer at iBio, Inc, from SEC Form 4 filings since Jul 31, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | IBIO iBio, Inc | Bought (not open market) | — |
Companies traded
- IBIO iBio, Inc: other filings, last Jul 31, 2026